News

Controversial Alzheimer’s drug, explained: What to know about Aduhelm, FDA and scathing report

Nada Hassanein, USA TODAY Comments Off on Controversial Alzheimer’s drug, explained: What to know about Aduhelm, FDA and scathing report

An investigation found the approval process for the controversial drug included "atypical collaboration" between the FDA and developer Biogen.

     
Nada Hassanein, USA TODAY
https://api-internal.usatoday.com.akadns.net

Related Articles
News

2017 in review: The ‘Wonder’-filled highs (and lows) of the year in movies

USA TODAY

USA TODAY looks at the highs (‘Wonder Woman’) and lows (‘Valerian and the City of a Thousand Planets’) of the year’s movies.
News

Shooter among dead in New Mexico high school shooting

The (Farmington, N.M.) Daily Times

Two students were killed when a shooter opened fire at Aztec High School.
News

Nativity scene and Christmas tree unveiled at the Vatican

Newslook

Nativity scene and Christmas tree unveiled at the Vatican Video provided by AFP